Conversely, treatment with tamoxifen and raloxifene, which inhibits ER activity in the breast, and aromatase inhibitors, which reduce endogenous estrogen production, are effective for treating and preventing ER+ breast cancer [119,120]. The gene discussed is ESR1; the disease is breast cancer.